Institutional Ownership Avidity Biosciences, Inc. (RNA)
This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 243 institutions that hold shares in the stock, with a total of 116 Million shares, which have been reported (via 13F filing form) to have a value of $3.34 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
714,224
shares
|
$20.6 Million
3.9% of portfolio
|
Q1 2025
Added 1.6%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
597,995
shares
|
$17.2 Million
0.0% of portfolio
|
Q1 2025
Added 190.42%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
557,576
shares
|
$16.1 Million
1.29% of portfolio
|
Q4 2024
Reduced 26.4%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
525,696
shares
|
$15.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 56.69%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
525,000
shares
|
$15.1 Million
0.98% of portfolio
|
Q1 2025
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
455,195
shares
|
$13.1 Million
0.02% of portfolio
|
Q1 2025
Added 179.5%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
440,802
shares
|
$12.7 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.08%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
439,099
shares
|
$12.6 Million
0.08% of portfolio
|
Q1 2025
Added 21.73%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
433,142
shares
|
$12.5 Million
0.01% of portfolio
|
Q1 2025
Added 4.33%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
431,211
shares
|
$12.4 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Alethea Capital Management, LLC
San Diego, CA |
May 14, 2025 Q1 2025 |
421,724
shares
|
$12.1 Million
9.31% of portfolio
|
Q1 2025
Added 0.2%
|
|
|
Silverarc Capital Management, LLC
|
May 14, 2025 Q1 2025 |
411,312
shares
|
$11.8 Million
2.96% of portfolio
|
Q1 2025
Reduced 24.34%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2025 Q1 2025 |
400,000
shares
|
$11.5 Million
1.25% of portfolio
|
Q1 2025
Reduced 61.9%
|
|
|
Finepoint Capital LP
Boston, MA |
May 14, 2025 Q1 2025 |
380,700
shares
|
$11 Million
1.19% of portfolio
|
Q1 2025
Reduced 2.71%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
379,931
shares
|
$10.9 Million
0.83% of portfolio
|
Q1 2025
Added 2655.32%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
377,279
shares
|
$10.9 Million
0.01% of portfolio
|
Q1 2025
Added 98.62%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
375,924
shares
|
$10.8 Million
0.24% of portfolio
|
Q2 2024
New holding
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
357,718
shares
|
$10.3 Million
0.0% of portfolio
|
Q1 2025
Added 7.62%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
352,498
shares
|
$10.2 Million
0.0% of portfolio
|
Q4 2024
Reduced 66.7%
|
|
|
Logos Global Management LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
350,000
shares
|
$10.1 Million
2.01% of portfolio
|
Q1 2025
New holding
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Jun 18, 2025 Q1 2025 |
332,180
shares
|
$9.57 Million
0.01% of portfolio
|
Q1 2025
Reduced 4.05%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
329,978
shares
|
$9.5 Million
0.02% of portfolio
|
Q1 2025
Added 1080.6%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
323,895
shares
|
$9.33 Million
0.0% of portfolio
|
Q1 2025
Added 29.55%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
288,139
shares
|
$8.3 Million
0.0% of portfolio
|
Q1 2025
Added 204.06%
|
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
279,828
shares
|
$8.06 Million
0.02% of portfolio
|
Q1 2025
Added 523.06%
|